Radforsk Investment Foundation has granted five research projects a total amount of NOK 4,95 million to further develop exciting research projects within photodynamic treatment and photochemical internalization. Cancer researcher Pål Selbo receives NOK 3,75 million for his project. Radforsk Investment Foundation is an evergreen investor focusing on companies that develop cancer treatment. “Radforsk has invested […]
Author Archive for: oslocancer
About Elisabeth Kirkeng Andersen
This author has yet to write their bio.Meanwhile lets just say that we are proud Elisabeth Kirkeng Andersen contributed a whooping 500 entries.
Entries by Elisabeth Kirkeng Andersen
Oslo Cancer Cluster har uttalt seg om Perspektivmeldingen 2021.
Lytix Biopharma enters into an exclusive license agreement with the Arctic University of Norway (UiT).
We participated in the influential technology conference SXSW2021.
OCC Accelerator will help start-ups in cancer innovation succeed.
Putting a spotlight on equality in cancer research
Kerstin Jakobsson wants to bring personalised health to proton therapy.
Students learned about how to raise capital for a start-up company.
Seahorse instrument helps researchers develop novel cell therapies.
Årets første møte i serien Fremtidens kreftbehandling ble avholdt digitalt onsdag 10. februar.
Contact us >
Oslo Cancer Cluster Innovation Park opened in May 2015.
The Innovation Park brings together the oncology-value chain from basic research to industry within the Oslo-area.
Our vision is to create Europe's leading environment for education, research and industry within oncology, shortening the development time of new cancer treatments.